The primary sequence of the prion protein affects susceptibility to transmissible spongiform encephalopathies, or prion diseases, in mice, sheep and humans. The Prnp gene sequence of free-ranging, Wisconsin white-tailed deer was determined and the Prnp genotypes of chronic wasting disease (CWD)-positive and CWD-negative deer were compared. Six amino acid changes were identified, two of which were located in pseudogenes. Two alleles, a QRK polymorphism at codon 226 and a single octapeptide repeat insertion into the pseudogene, have not been reported previously. The predominant alleles -wild-type (Q95, G96 and Q226) and a G96S polymorphism -comprised almost 98 % of the Prnp alleles in the Wisconsin white-tailed deer population. Comparison of the allelic frequencies in the CWD-positive and CWD-negative deer suggested that G96S and a Q95H polymorphism were linked to a reduced susceptibility to CWD. The G96S allele did not, however, provide complete resistance, as a CWD-positive G96S/G96S deer was identified. The G96S allele was also linked to slower progression of the disease in CWD-positive deer based on the deposition of PrP CWD in the obex region of the medulla oblongata.
INTRODUCTION
Chronic wasting disease (CWD) is the cervid form of a class of fatal neurodegenerative diseases known as transmissible spongiform encephalopathies (TSEs) or prion diseases. The linkage of the prion protein (PrP) gene, Prnp, to TSE susceptibility is well documented in mice (Dickinson et al., 1968; Westaway et al., 1987) , sheep (Tranulis, 2002) and humans (Prusiner & Scott, 1997) . Variability in Prnp probably affects CWD susceptibility in cervid populations. In elk, variability at PrP codon 132 was found to have a significant influence on susceptibility to CWD (O'Rourke et al., 1999) . Mule deer heterozygous for serine and phenylalanine (S/F heterozygous) or F/F homozygous at codon 225 were underrepresented in the infected population, suggesting decreased susceptibility to CWD (Jewell et al., 2005) . Genetic analysis also suggests that the susceptibility of white-tailed deer to CWD is influenced by polymorphisms at codon 96 (Johnson et al., 2003; O'Rourke et al., 2004) and codon 116 , although the relatively small sample sizes in both studies allowed only limited conclusions.
Our initial assessment of the sequence of the Prnp gene of white-tailed deer revealed three PrP alleles (Johnson et al., 2003) . The most common allele, referred to as wild-type (wt), encoded Q95 and G96. Alleles encoding a Q95H polymorphism and a G96S polymorphism were also present in this population. White-tailed deer populations in the western region of the USA show additional Prnp polymorphisms of G65E and A116G (Heaton et al., 2003) . A previously characterized polymorphism at codon 138 (S138N; Raymond et al., 2000; Johnson et al., 2003) was determined to be a processed pseudogene in both mule deer and white-tailed deer .
In this study, a larger number of infected and uninfected free-ranging deer was analysed. Significantly fewer Q95H and G96S PrP alleles were found in the CWD-positive population compared with the CWD-negative population. Immunohistochemical scoring of CWD progression supported a reduced rate of disease progression in deer heterozygous for PrP allele G96S. We also identified two additional Prnp polymorphisms present in both infected and uninfected deer populations. . Testing for CWD in these deer populations was performed primarily on the RPLNs. In a separate study (unpublished observations), obex tissue from several thousand deer that were CWD-negative in the RPLNs was stained for PrP CWD deposition. All RPLN-negative animals were also obex-negative.
METHODS
Amplification and sequencing of the white-tailed deer Prnp.
The Prnp gene was sequenced from 624 Wisconsin white-tailed deer: 292 CWD-positive and 153 CWD-negative deer from the southcentral CWD-affected region and 179 CWD-negative deer from outside the CWD-affected region. Genomic DNA was isolated from ear or muscle tissue and the coding region of the Prnp gene was amplified as described previously (Johnson et al., 2003) . The primer set used was: CWD-13 (59-TTTTGCAGATAAGTCATCATGGTGA-AA-39, nt 13-39) and CWD-LA (59-AGAAGATAATGAAAACAGG-AAGGTTGC-39, nt 830-804). The nucleotide numbering for Prnp is based on the cervid sequence in GenBank (GenBank accession no. AF156185). PCR amplification and sequencing reactions were performed as described previously (Johnson et al., 2003) . Primer sets CWD-13, CWD-LA, CWD-161 (59-AGGGAAGTCCTGGAGGCAA-CCGCTATCC-39, nt 161-188) and CWD-418 (59-CACCAAGGCC-CCCTACCACTGCTCCAGC-39, nt 418-391) were used for sequencing. All samples that appeared to be heterozygous with respect to Prnp alleles were cloned and sequenced to determine the allele with which the polymorphism was associated. Sequences were analysed using DNAStar or EditView and MacVector 6.5 software.
Identification of the S138N pseudogene. Two methods were employed to determine whether the S138N change detected in the Wisconsin white-tailed deer population was a processed pseudogene. A step-down PCR genome-walking protocol, described by Zhang & Gurr (2000) , was adapted to characterize the 59 and 39 flanking regions of the white-tailed deer Prnp open reading frame (ORF). Using a white-tailed deer Prnp-specific and an adaptor-specific primer, nested PCR was subsequently performed to amplify the 59 and 39 regions flanking the ORF. The primers used for specific amplification of white-tailed deer Prnp were selected from regions not expected to have polymorphisms and are shown in Table 1 . PCR products were gel purified, cloned and sequenced using T7-and SP6-specific primers (Promega), as described previously (Johnson et al., 2003) .
The second approach involved cloning PCR-amplified Prnp from deer identified by direct sequencing as heterozygous for the G96S and S138N polymorphisms. The ORFs were amplified, cloned and sequenced as described above.
IHC for PrP
CWD scoring in the obex. Deer that tested positive for CWD in the RPLNs were analysed for the level of PrP CWD deposition in the obex using IHC as described previously (Spraker et al., 2002) , but omitting the initial formic acid treatment. Scoring was performed blind, i.e. without prior knowledge of the Prnp genetics. Briefly, obex tissues from 139 CWD-positive animals were fixed in 10 % neutral buffered formalin, dehydrated and embedded in paraffin. Tissue sections (5 mm) were mounted on positively charged slides, deparaffinized and exposed to hydrated autoclaving in antigen retrieval buffer. The tissue sections were exposed to antiPrP mAb F99/97.6.1, which recognizes the conserved QYQRES peptide (Spraker et al., 2002) , using a NexES automated immunostainer (Ventana Medical Systems). Primary antibody binding was detected using a biotinylated secondary anti-mouse antibody, followed by horseradish peroxidase-streptavidin conjugate and chromagen substrate. Obex tissue was assessed for the distribution of PrP CWD deposition and scored with a value of between 0 and 4 as follows: 0, no staining in the obex; 1, a low level of staining in the obex dorsal motor nucleus of the vagus nerve (DMNV); 2, positive staining in the entire DMNV; 3, staining beyond the DMNV; 4, a high level of staining throughout the obex. The PrP CWD staining data were aligned with the Prnp genotype data.
Statistical analysis. To estimate the proportion of the white-tailed deer population in the CWD-affected region that were genetically susceptible to CWD, we constructed a 95 % confidence interval based on a large-sample approximation to the binomial distribution using the allelic combination frequencies in the CWD-negative population. x 2 analysis was used to determine whether differences in allelic combination percentages between CWD-positive and CWD-negative deer populations were significant. PrP deposition in the obex was analysed using the GLM procedure (SAS). A one-way analysis of variance was used to compare mean obex scores for deer with different Prnp alleles. Individual genotype means were compared using Fisher's least significant difference (P<0?05).
RESULTS

White-tailed deer PrP polymorphisms
An extended sequence analysis of Prnp from free-ranging white-tailed deer identified two novel Prnp alleles, a Q226K polymorphism and a single octapeptide repeat insertion at codon 63 in the S138N pseudogene ORF. The PrP allele with codons Q95, G96 and Q226, referred to as wt, was the most prevalent in the population (Fig. 1) . Analysis of the 59 region flanking the Prnp ORF of the wt, Q95H, G96S and Q226K alleles suggested that they were all functional genes.
Approximately 98 % of the functional Prnp genes in the CWD-negative white-tailed deer population comprised two major alleles, wt (71?9 %) and G96S (25?8 %). The Prnp genotypes present in the CWD-positive and CWD-negative deer populations in the CWD-affected region of Wisconsin were significantly different from each other (P<0?001; Fig. 1 ). In the CWD-positive deer population, 81?5 % of the animals were wt/wt compared with 51 % of the CWDnegative deer (Fig. 2) . The wt/wt genotype was significantly overrepresented in the infected deer population (P<0?0001). Conversely, 17?4 % of CWD-positive deer had at least one copy of the G96S allele, compared with 44?4 % of CWD-negative deer. The wt/G96S and G96S/G96S genotypes represented 39?2 and 5?2 % of the CWD-negative animals, respectively; however, significantly fewer CWDpositive deer were identified with these alleles [17?1 % (P<0?0001) and 0?3 % (P=0?0005), respectively) (Fig. 2) . In addition to the G96S allele, deer heterozygous for the Q95H allele were also significantly underrepresented in the CWD-positive population (P=0?007). No Q95H allele was identified in the CWD-positive deer population, whilst 3?9 % of the CWD-negative deer assessed from the affected region were heterozygous for the Q95H allele.
The S138N allele is a processed pseudogene in Wisconsin white-tailed deer
The S138N allele has been identified as a processed pseudogene in western mule deer and captive white-tailed deer (O'Rourke et al., 2004). Since our initial primers did not differentiate between functional and non-functional genes (amplifying only the ORF), we used two approaches to characterize further the S138N allele in Wisconsin white-tailed deer. All amplification products from heterozygous deer were cloned and sequenced. Three unique Prnp clones were isolated and characterized from a single animal, G96S, S138N and wt, indicating the presence of at least one additional copy of Prnp. Following step-down genome walking, the 59 upstream region of Prnp was also sequenced. A BLAST search against GenBank, using the Prnp sequence from the 59 untranslated region of the allele with the S138N change, showed 98 % sequence similarity to the mule deer processed pseudogene (GenBank accession no. AY371694). There was no significant difference between CWD-positive and CWD-negative deer for the presence of the pseudogene (20?9 % and 18?3 %, respectively; P=0?5165).
Prnp allele frequencies are similar inside and outside the wDEZ White-tailed deer in Wisconsin are non-migratory. To determine whether the allele frequencies observed within the wDEZ were specific to the endemic area, Prnp genotypes were also determined for free-ranging white-tailed deer located 100-300 miles outside the wDEZ. All of these deer tested negative by IHC. The three major Prnp alleles identified in deer from the CWD-affected region also comprised the majority of the alleles in these deer. The frequency of alleles was similar to the allele frequencies observed in uninfected animals in the CWD-affected region: 76?8 % wt, 21?8 % G96S and 1?4 % Q95H.
Analysis of disease progression in the obex of infected animals
Since the G96S allele was less prevalent in the infected population, suggesting reduced susceptibility to CWD, we hypothesized that CWD would progress at a slower rate in infected deer with the G96S allele. To determine whether the presence of the G96S allele affected progression of the disease, the intensity and distribution of PrP CWD staining in the obex of the medulla oblongata was assessed, without prior knowledge of the Prnp genotypes, and correlated with identified Prnp genotypes (Fig. 3) . The mean stage of obex disease progression, as determined by PrP CWD staining, was 2?13±0?05 (n=86) in wt/wt deer and 2?29±0?07 (n=31) in wt/wt/pseudogene deer, compared with only 1?32±0?11 (n=22) in wt/G96S deer. The mean obex staining level in wt/G96S deer was significantly less than in animals with the other genotypes (P<0?05), whereas no significant difference was identified in CWD progression in wt/wt deer with or without the pseudogene. The only CWD-positive deer homozygous for G96S was positive for the presence of PrP CWD in the RPLN but not in the obex, precluding an analysis of disease progression in the animal.
DISCUSSION
Polymorphisms in the primary sequence of PrP can strongly influence susceptibility to prion diseases, as demonstrated in sheep, mice and humans. Sequence analysis of Prnp from white-tailed deer from the CWD-affected region of Wisconsin that were positive or negative for PrP CWD by IHC revealed a bias in the Prnp genotypes between the two populations. The predominant Prnp allele in the CWDpositive and CWD-negative populations encoded Q, G and Q at codons 95, 96 and 226, respectively. The G96S allele was the second most prevalent allele in the population. Of the possible combinations of Prnp alleles, deer homozygous or heterozygous for the G96S allele and deer heterozygous for the Q95H allele were significantly underrepresented in the CWD-positive population compared with CWD-negative deer from the same region. In contrast, wt homozygous deer were overrepresented in the CWD-positive deer population. The presence of the Prnp pseudogene did not appear to influence the susceptibility of white-tailed deer to CWD.
The mean level of PrP CWD staining in the obex of CWDpositive deer was lower in animals with the G96S allele, suggesting that disease progression is retarded in these animals. CWD-positive white-tailed deer that were homozygous for the G96S have been reported in a captive population . The one homozygous G96S CWD-positive Wisconsin white-tailed deer was weakly positive in its RPLNs (unpublished data), with no PrP CWD deposition observed in other peripheral lymph nodes tested or in the obex of this animal. This deer was harvested from a wild population and thus the dose and time of infection were unknown. Controlled oral inoculations will be required to determine the degree to which the G96S allele affects the susceptibility of white-tailed deer to CWD.
The association of the G96S allele with reduced susceptibility has been noted in captive white-tailed deer , although with less impact on susceptibility than is suggested by our data. Several factors may contribute to this apparent difference in genetic effect on susceptibility. The strain of agent in the two populations may be different. The high percentage of positive deer in the captive population would suggest that CWD was present in that population for several years and may have adapted to passage in deer with at least one copy of the G96S allele. Conversely, the density of deer and the high prevalence of infected animals in the captive population could result in high levels of exposure to the agent. If the G96S allele provides moderate resistance to CWD, high titres of agent may overcome genetic resistance.
An in vitro means of determining the molecular compatibility between PrP C and PrP Sc , the cell-free conversion assay, has been used to estimate genetic susceptibility to CWD (Raymond et al., 2000) . When PrP C from different alleles of white-tailed deer Prnp was combined with CWD agent from white-tailed deer in the cell-free conversion assay, it appeared that both wt (GMSQ in Raymond et al., 2000) and G96S (SMSQ in Raymond et al., 2000) were converted to PrP res with similar efficiencies. Although these data appear to contradict our population genetics study, there are several explanations for the differences. The cell-free conversion assay is indicative of the molecular interaction between the normal and abnormal forms of PrP and does not account for the dose, strain of agent and route of infection, all of which can affect the likelihood of PrP Sc and PrP C interacting. The study by Raymond et al. (2000) used CWD agent from western white-tailed deer and it is not yet known whether the agent from Colorado/Wyoming is the same as the Wisconsin strain. In vivo strain differences are not necessarily reflected in the cell-free conversion assay. For example, both the HY and DY strains of hamster-adapted transmissible mink encephalopathy convert hamster PrP C to PrP res in a strain-specific manner in cell-free conversion assays (Bessen et al., 1995; Iniguez et al., 2000) . Although HY and DY agents result in clinical disease when the hamsters are infected by the intracerebral route, DY does not cause disease when the route of infection is intraperitoneal or oral (Bartz et al., 2004) . Cell-free conversion assays have also suggested that different PrP isoforms from elk are converted equivalently by infectious agent from elk (Raymond et al., 2000) . However, Hamir et al. (2006) demonstrated that, in experimental oral infection experiments, the 132LL genotype is much less susceptible, with 132MM animals becoming clinically positive at 23 months post-infection, whilst 132LL animals are still clinically normal at 48 months.
The deer in the wDEZ were randomly sampled and thus it is possible that the number of CWD-positive deer with at least one G96S allele was artificially low due to variability in exposure to CWD. Therefore, we assessed the distribution of deer within the wDEZ. The location of harvest for each CWD-positive deer was determined using the deer harvest database maintained by the Wisconsin Department of Natural Resources. The same database was then used to identify CWD-negative animals (n=107) harvested within 1 square mile of CWD-positive deer (data not shown). At least one copy of the G96S allele was present in 51?5 % of these animals, compared with 46?4 % of all sequenced CWD-negative deer in the wDEZ, suggesting that lack of exposure to CWD was not a reason for the underrepresentation of G96S in the CWD-positive population.
Sequencing of Prnp from white-tailed deer outside the CWD-affected region of Wisconsin was performed to identify potential genetic barriers to disease spread and potential reservoirs for strain development and to establish basal allelic levels for future studies of disease impact on genetic drift. Given the homogeneous distribution of white-tailed deer Prnp alleles between the deer populations of the CWD-affected region and deer 100-300 miles distant from that population, it is likely that our results in the CWD-affected region are indicative of what can be expected for a much greater regional deer population. Localized areas of different Prnp allelic profiles may exist; however, our data suggest that there is no genetic barrier to CWD spread through the regional deer population. Previously, we estimated that~91 % of the CWD-negative deer had allelic combinations present in CWD-positive deer, suggesting that there is no major genetic barrier to transmission in the deer population (Johnson et al., 2003) . From the results of this increased analysis of Prnp alleles in CWD-positive deer, we estimate that 91-98 % of white-tailed deer are genetically susceptible to CWD.
